capivasertib fulvestrant improves progression-free survival in advanced hr breast cancer patients
Published 1 year ago • 289 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
2:15
capivasertib in advanced breast cancer | nejm
-
5:28
capitello-291: capivasertib fulvestrant for ai-resistant hr /her2- advanced breast cancer
-
6:44
cdk4/6 inhibitor ribociclib plus fulvestrant improves overall survival in postmenopausal hr-posi...
-
23:20
ibrance
-
5:12
monaleesa-3: ribociclib plus fulvestrant in hr mbc
-
8:47
what's new in breast cancer treatment in 2023 | top breast cancer docs discuss emerging research
-
14:02
approval of capivasertib for pik3ca/akt1/pten–altered breast cancer: jason mouabbi and carlos doti
-
13:54
overall survival results from monaleesa-2: endocrine therapy and ribociclib in hr positive and h...
-
0:11
fulvant (fulvestrant) breast cancer medicine
-
0:58
results of capitello291 - capivasertib
-
3:05
overall survival with palbociclib plus fulvestrant
-
2:56
fulvestrant in falcon trial improves pfs in advanced breast cancer
-
1:29
capitello-292: capivasertib, palbociclib, and fulvestrant for hr endocrine-resistant breast cancer
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
1:05
moving away from chemotherapy to treat hr-positive/her2-negative metastatic breast cancer
-
0:52
background on capivasertib - now approved for breast cancer
-
5:10
paloma-3: overall survival (os) with palbociclib plus fulvestrant in hr ,her2_ abc
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
3:02
paloma-3: palbociclib plus fulvestrant in hormone receptor-positive advanced breast cancer
-
1:15:47
evolving landscape of hr-positive metastatic breast cancer: a year in review
-
5:28
comment: fulvestrant improves survival over anastrozole for patients with advanced breast cancer